145 related articles for article (PubMed ID: 32767281)
1. No Independent Association of Circulating Fetuin-A with Insulin Sensitivity in Young Women.
Reif S; Moschko S; Gar C; Ferrari U; Hesse N; Sommer NN; Seißler J; Lechner A
Horm Metab Res; 2020 Nov; 52(11):809-814. PubMed ID: 32767281
[TBL] [Abstract][Full Text] [Related]
2. Changes Over Time in Hepatic Markers Predict Changes in Insulin Sensitivity, β-Cell Function, and Glycemia.
Pinnaduwage L; Ye C; Hanley AJ; Connelly PW; Sermer M; Zinman B; Retnakaran R
J Clin Endocrinol Metab; 2018 Jul; 103(7):2651-2659. PubMed ID: 29897453
[TBL] [Abstract][Full Text] [Related]
3. Effects of dynamic change in fetuin-A levels from the first to the second trimester on insulin resistance and gestational diabetes mellitus: a nested case-control study.
Jin C; Lin L; Han N; Zhao Z; Liu Z; Luo S; Xu X; Liu J; Wang H
BMJ Open Diabetes Res Care; 2020 Jan; 8(1):. PubMed ID: 31958310
[TBL] [Abstract][Full Text] [Related]
4. Impact of the adipokine adiponectin and the hepatokine fetuin-A on the development of type 2 diabetes: prospective cohort- and cross-sectional phenotyping studies.
Stefan N; Sun Q; Fritsche A; Machann J; Schick F; Gerst F; Jeppesen C; Joost HG; Hu FB; Boeing H; Ullrich S; Häring HU; Schulze MB
PLoS One; 2014; 9(3):e92238. PubMed ID: 24643166
[TBL] [Abstract][Full Text] [Related]
5. Circulating Fetuin-A and Risk of Type 2 Diabetes: A Mendelian Randomization Analysis.
Kröger J; Meidtner K; Stefan N; Guevara M; Kerrison ND; Ardanaz E; Aune D; Boeing H; Dorronsoro M; Dow C; Fagherazzi G; Franks PW; Freisling H; Gunter MJ; Huerta JM; Kaaks R; Key TJ; Khaw KT; Krogh V; Kühn T; Mancini FR; Mattiello A; Nilsson PM; Olsen A; Overvad K; Palli D; Quirós JR; Rolandsson O; Sacerdote C; Sala N; Salamanca-Fernández E; Sluijs I; Spijkerman AMW; Tjonneland A; Tsilidis KK; Tumino R; van der Schouw YT; Forouhi NG; Sharp SJ; Langenberg C; Riboli E; Schulze MB; Wareham NJ
Diabetes; 2018 Jun; 67(6):1200-1205. PubMed ID: 29523632
[TBL] [Abstract][Full Text] [Related]
6. Fetuin-A in newly detected type 2 diabetes mellitus as a marker of non-alcoholic fatty liver disease.
Yamasandhi PG; Dharmalingam M; Balekuduru A
Indian J Gastroenterol; 2021 Dec; 40(6):556-562. PubMed ID: 34950996
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the novel adipokines/ hepatokines fetuin A and fetuin B in gestational diabetes mellitus.
Kralisch S; Hoffmann A; Lössner U; Kratzsch J; Blüher M; Stumvoll M; Fasshauer M; Ebert T
Metabolism; 2017 Mar; 68():88-94. PubMed ID: 28183456
[TBL] [Abstract][Full Text] [Related]
8. Role of fetuin-A in atherosclerosis associated with diabetic patients.
Singh M; Sharma PK; Garg VK; Mondal SC; Singh AK; Kumar N
J Pharm Pharmacol; 2012 Dec; 64(12):1703-8. PubMed ID: 23146032
[TBL] [Abstract][Full Text] [Related]
9. Comparative effects of metformin and pioglitazone on fetuin-A and osteoprotegerin concentrations in patients with newly diagnosed diabetes: A randomized clinical trial.
Esteghamati A; Afarideh M; Feyzi S; Noshad S; Nakhjavani M
Diabetes Metab Syndr; 2015; 9(4):258-65. PubMed ID: 25450818
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of fetuin A are increased in women with gestational diabetes mellitus.
Iyidir OT; Degertekin CK; Yilmaz BA; Altinova AE; Toruner FB; Bozkurt N; Ayvaz G; Akturk M
Arch Gynecol Obstet; 2015 Apr; 291(4):933-7. PubMed ID: 25260988
[TBL] [Abstract][Full Text] [Related]
11. The hepatokines fetuin-A and fetuin-B are upregulated in the state of hepatic steatosis and may differently impact on glucose homeostasis in humans.
Peter A; Kovarova M; Staiger H; Machann J; Schick F; Königsrainer A; Königsrainer I; Schleicher E; Fritsche A; Häring HU; Stefan N
Am J Physiol Endocrinol Metab; 2018 Mar; 314(3):E266-E273. PubMed ID: 29138227
[TBL] [Abstract][Full Text] [Related]
12. High plasma fetuin-A levels are associated with metabolic syndrome among males but not females in a Japanese general population.
Obuchi A; Adachi H; Enomoto M; Fukami A; Kumagai E; Nakamura S; Yoshimura A; Nohara Y; Nakao E; Umeki Y; Fukumoto Y; Imaizumi T
Diabetes Res Clin Pract; 2014 Oct; 106(1):128-35. PubMed ID: 25110104
[TBL] [Abstract][Full Text] [Related]
13. Cardiometabolic correlates and heritability of fetuin-A, retinol-binding protein 4, and fatty-acid binding protein 4 in the Framingham Heart Study.
Kaess BM; Enserro DM; McManus DD; Xanthakis V; Chen MH; Sullivan LM; Ingram C; O'Donnell CJ; Keaney JF; Vasan RS; Glazer NL
J Clin Endocrinol Metab; 2012 Oct; 97(10):E1943-7. PubMed ID: 22855337
[TBL] [Abstract][Full Text] [Related]
14. Circulating levels of fetuin-A are associated with moderate-severe hepatic steatosis in young adults.
Filardi T; Panimolle F; Tiberti C; Crescioli C; Lenzi A; Pallotta N; Morano S
J Endocrinol Invest; 2021 Jan; 44(1):105-110. PubMed ID: 32350824
[TBL] [Abstract][Full Text] [Related]
15. Fetuin-A in Metabolic syndrome: A systematic review and meta-analysis.
Pan X; Wen SW; Bestman PL; Kaminga AC; Acheampong K; Liu A
PLoS One; 2020; 15(3):e0229776. PubMed ID: 32134969
[TBL] [Abstract][Full Text] [Related]
16. Increased fetuin-A concentrations in impaired glucose tolerance with or without nonalcoholic fatty liver disease, but not impaired fasting glucose.
Ou HY; Yang YC; Wu HT; Wu JS; Lu FH; Chang CJ
J Clin Endocrinol Metab; 2012 Dec; 97(12):4717-23. PubMed ID: 23066121
[TBL] [Abstract][Full Text] [Related]
17. Can Fetuin-A Be a Marker for Insulin Resistance and Poor Glycemic Control in Children with Type 1 Diabetes Mellitus?
Şiraz ÜG; Doğan M; Hatipoğlu N; Muhtaroğlu S; Kurtoğlu S
J Clin Res Pediatr Endocrinol; 2017 Dec; 9(4):293-299. PubMed ID: 28529199
[TBL] [Abstract][Full Text] [Related]
18. Fetuin-A and risk of diabetes-related vascular complications: a prospective study.
Birukov A; Polemiti E; Jäger S; Stefan N; Schulze MB
Cardiovasc Diabetol; 2022 Jan; 21(1):6. PubMed ID: 34998417
[TBL] [Abstract][Full Text] [Related]
19. Fetuin-A and incident diabetes mellitus in older persons.
Ix JH; Wassel CL; Kanaya AM; Vittinghoff E; Johnson KC; Koster A; Cauley JA; Harris TB; Cummings SR; Shlipak MG;
JAMA; 2008 Jul; 300(2):182-8. PubMed ID: 18612115
[TBL] [Abstract][Full Text] [Related]
20. Metabolic crosstalk between fatty pancreas and fatty liver: effects on local inflammation and insulin secretion.
Gerst F; Wagner R; Kaiser G; Panse M; Heni M; Machann J; Bongers MN; Sartorius T; Sipos B; Fend F; Thiel C; Nadalin S; Königsrainer A; Stefan N; Fritsche A; Häring HU; Ullrich S; Siegel-Axel D
Diabetologia; 2017 Nov; 60(11):2240-2251. PubMed ID: 28791439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
